Related Experiment Video
Updated: Jun 26, 2026
07:32
Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles
Published on: August 28, 2015
Cellular automata model for drug release from binary matrix and reservoir polymeric devices
Timo Johannes Laaksonen1, Hannu Mikael Laaksonen, Jouni Tapio Hirvonen
1Division of Pharmaceutical Technology, University of Helsinki, P.O. Box 56 (Viikinkaari 5E), FI-00014 Helsinki, Finland. timo.laaksonen@helsinki.fi
Biomaterials
|January 13, 2009
Summary
A new cellular automata model simulates drug release from polymeric devices. This versatile model accurately predicts diffusion and erosion kinetics for various drug delivery systems.
Area of Science:
- Pharmacology and Materials Science
- Computational Modeling in Drug Delivery
Background:
- Understanding drug release kinetics from polymeric devices is crucial for effective drug delivery.
- Existing models may lack the versatility to simulate diverse release mechanisms like diffusion and erosion simultaneously.
Purpose of the Study:
- To introduce a novel, widely applicable cellular automata model for simulating drug release from polymeric devices.
- To demonstrate the model's capability in handling diffusion and erosion processes.
Main Methods:
- A 2D cellular automata model representing the drug release device was developed.
- Cells within the model simulate material, drug, polymer, or solvent, rearranging based on statistical rules.
- Diffusion is modeled via random cell walks, and kinetics via state conversion probabilities.
Main Results:
- The model was successfully applied to erodable matrices, channel/pore diffusion, and membrane-controlled release systems.
- Simulated dissolution curves showed good agreement with established analytical models.
- The model demonstrated compatibility and adaptability across different release mechanisms and device geometries.
Conclusions:
- The cellular automata model provides a robust and adaptable framework for simulating drug release kinetics.
- Its compatibility with various release mechanisms suggests broad applicability in designing polymeric drug delivery systems.
- The model offers potential for further extensions and applications in pharmaceutical research.
Related Concept Videos
01:19Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
01:22Modified-Release Drug Delivery Systems: Rate-Programmed I
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
01:30Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
01:23Modified-Release Drug Delivery Systems: Classification
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
01:18Transdermal Drug Delivery Systems
Transdermal drug delivery systems (TDDS) enable the controlled release of drugs across the skin into systemic circulation. They are particularly advantageous for drugs with short half-lives or narrow therapeutic indices, as they maintain consistent plasma concentrations and reduce the risk of subtherapeutic or toxic levels.TDDS are categorized into monolithic, reservoir, and mixed systems. Monolithic systems embed the drug in a polymer matrix, where diffusion governs release. Reservoir systems...
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...